Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,872 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
Naiki T, Okamura T, Nagata D, Mori Y, Kawai N, Ogawa K, Akita H, Hashimoto Y, Tozawa K, Kohri K. Naiki T, et al. Among authors: mori y. Asian Pac J Cancer Prev. 2011;12(4):909-13. Asian Pac J Cancer Prev. 2011. PMID: 21790224 Free article.
Efficiency of Skeletal Muscle Mass/Weight Measurement for Distinguishing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Analysis Using InBody Bioimpedance Devices.
Tatsuta M, Masaki T, Kimura S, Sato Y, Tomida A, Ishikawa I, Nakamura Y, Takuma K, Nakahara M, Oura K, Tadokoro T, Fujita K, Tani J, Morishita A, Himoto T, Miyazaki S, Maeta T, Mori Y, Kohi F, Kobara H. Tatsuta M, et al. Among authors: mori y. Nutrients. 2024 Dec 23;16(24):4422. doi: 10.3390/nu16244422. Nutrients. 2024. PMID: 39771043 Free PMC article.
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: TALAPRO-2 Japanese Subgroup Analysis.
Matsubara N, Miyake H, Uemura H, Mizokami A, Kikukawa H, Kosaka T, Nishimura K, Nakamura M, Kobayashi K, Komaru A, Mori Y, Toyoizumi S, Hori N, Umeyama Y, Uemura H. Matsubara N, et al. Among authors: mori y. Cancer Med. 2025 Jan;14(1):e70333. doi: 10.1002/cam4.70333. Cancer Med. 2025. PMID: 39737542 Free PMC article. Clinical Trial.
5,872 results